nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—Telmisartan—coronary artery disease	0.141	0.406	CrCtD
Olmesartan—AGTR1—coronary artery disease	0.117	1	CbGaD
Olmesartan—Valsartan—coronary artery disease	0.111	0.321	CrCtD
Olmesartan—Losartan—coronary artery disease	0.0945	0.273	CrCtD
Olmesartan—AGTR1—Telmisartan—coronary artery disease	0.0265	0.116	CbGbCtD
Olmesartan—AGTR1—Valsartan—coronary artery disease	0.0258	0.113	CbGbCtD
Olmesartan—Azilsartan medoxomil—Telmisartan—coronary artery disease	0.0246	0.11	CrCrCtD
Olmesartan—Irbesartan—Valsartan—coronary artery disease	0.0168	0.075	CrCrCtD
Olmesartan—Forasartan—Valsartan—coronary artery disease	0.0168	0.075	CrCrCtD
Olmesartan—Telmisartan—Losartan—coronary artery disease	0.0165	0.0738	CrCrCtD
Olmesartan—Azilsartan medoxomil—Losartan—coronary artery disease	0.0165	0.0738	CrCrCtD
Olmesartan—Losartan—Telmisartan—coronary artery disease	0.0154	0.0686	CrCrCtD
Olmesartan—Tasosartan—Valsartan—coronary artery disease	0.0148	0.0663	CrCrCtD
Olmesartan—AGTR1—Losartan—coronary artery disease	0.0148	0.0648	CbGbCtD
Olmesartan—Irbesartan—Losartan—coronary artery disease	0.0143	0.0638	CrCrCtD
Olmesartan—Valsartan—Losartan—coronary artery disease	0.0143	0.0638	CrCrCtD
Olmesartan—Forasartan—Losartan—coronary artery disease	0.0143	0.0638	CrCrCtD
Olmesartan—Candesartan—Telmisartan—coronary artery disease	0.0141	0.0631	CrCrCtD
Olmesartan—Tasosartan—Losartan—coronary artery disease	0.0126	0.0564	CrCrCtD
Olmesartan—SLCO1B3—Telmisartan—coronary artery disease	0.0122	0.0534	CbGbCtD
Olmesartan—SLCO1B3—Pitavastatin—coronary artery disease	0.0122	0.0534	CbGbCtD
Olmesartan—Losartan—Valsartan—coronary artery disease	0.0121	0.0543	CrCrCtD
Olmesartan—SLCO1B3—Valsartan—coronary artery disease	0.0119	0.0519	CbGbCtD
Olmesartan—Candesartan—Valsartan—coronary artery disease	0.0112	0.0499	CrCrCtD
Olmesartan—Candesartan—Losartan—coronary artery disease	0.00949	0.0424	CrCrCtD
Olmesartan—SLCO1B1—Gemfibrozil—coronary artery disease	0.00938	0.041	CbGbCtD
Olmesartan—SLCO1B3—Rosuvastatin—coronary artery disease	0.009	0.0394	CbGbCtD
Olmesartan—SLCO1B3—Pravastatin—coronary artery disease	0.00818	0.0358	CbGbCtD
Olmesartan—SLCO1B3—Atorvastatin—coronary artery disease	0.00745	0.0326	CbGbCtD
Olmesartan—SLCO1B1—Pitavastatin—coronary artery disease	0.00711	0.0311	CbGbCtD
Olmesartan—SLCO1B1—Valsartan—coronary artery disease	0.00691	0.0302	CbGbCtD
Olmesartan—SLCO1B3—Losartan—coronary artery disease	0.00682	0.0298	CbGbCtD
Olmesartan—ABCC2—Pitavastatin—coronary artery disease	0.00624	0.0273	CbGbCtD
Olmesartan—ABCC2—Telmisartan—coronary artery disease	0.00624	0.0273	CbGbCtD
Olmesartan—SLCO1B1—Ezetimibe—coronary artery disease	0.00524	0.0229	CbGbCtD
Olmesartan—SLCO1B1—Rosuvastatin—coronary artery disease	0.00524	0.0229	CbGbCtD
Olmesartan—SLCO1B1—Simvastatin—coronary artery disease	0.00487	0.0213	CbGbCtD
Olmesartan—SLCO1B1—Lovastatin—coronary artery disease	0.00477	0.0209	CbGbCtD
Olmesartan—SLCO1B1—Pravastatin—coronary artery disease	0.00477	0.0209	CbGbCtD
Olmesartan—ABCC2—Ezetimibe—coronary artery disease	0.0046	0.0201	CbGbCtD
Olmesartan—SLCO1B1—Atorvastatin—coronary artery disease	0.00434	0.019	CbGbCtD
Olmesartan—ABCC2—Simvastatin—coronary artery disease	0.00428	0.0187	CbGbCtD
Olmesartan—ABCC2—Pravastatin—coronary artery disease	0.00419	0.0183	CbGbCtD
Olmesartan—ABCC2—Lovastatin—coronary artery disease	0.00419	0.0183	CbGbCtD
Olmesartan—SLCO1B1—Losartan—coronary artery disease	0.00397	0.0174	CbGbCtD
Olmesartan—ABCC2—Atorvastatin—coronary artery disease	0.00381	0.0167	CbGbCtD
Olmesartan—ABCC2—Furosemide—coronary artery disease	0.00356	0.0156	CbGbCtD
Olmesartan—Azilsartan medoxomil—AGTR1—coronary artery disease	0.000258	0.17	CrCbGaD
Olmesartan—Forasartan—AGTR1—coronary artery disease	0.00024	0.158	CrCbGaD
Olmesartan—Tasosartan—AGTR1—coronary artery disease	0.000146	0.0959	CrCbGaD
Olmesartan—AGTR1—artery—coronary artery disease	0.000145	0.213	CbGeAlD
Olmesartan—Irbesartan—EDNRA—coronary artery disease	0.000143	0.0945	CrCbGaD
Olmesartan—Valsartan—AGTR1—coronary artery disease	0.000126	0.0832	CrCbGaD
Olmesartan—AGTR1—endothelium—coronary artery disease	0.000122	0.18	CbGeAlD
Olmesartan—Telmisartan—AGTR1—coronary artery disease	0.000119	0.0782	CrCbGaD
Olmesartan—Irbesartan—AGTR1—coronary artery disease	9.56e-05	0.063	CrCbGaD
Olmesartan—Candesartan—AGTR1—coronary artery disease	9.56e-05	0.063	CrCbGaD
Olmesartan—AGTR1—cardiac ventricle—coronary artery disease	8.12e-05	0.119	CbGeAlD
Olmesartan—AGTR1—myocardium—coronary artery disease	7.64e-05	0.112	CbGeAlD
Olmesartan—Telmisartan—PPARG—coronary artery disease	7.47e-05	0.0492	CrCbGaD
Olmesartan—Losartan—AGTR1—coronary artery disease	6.16e-05	0.0406	CrCbGaD
Olmesartan—AGTR1—heart—coronary artery disease	5.33e-05	0.0784	CbGeAlD
Olmesartan—Telmisartan—CYP2C19—coronary artery disease	5.06e-05	0.0334	CrCbGaD
Olmesartan—AGTR1—cardiovascular system—coronary artery disease	5.03e-05	0.074	CbGeAlD
Olmesartan—AGTR1—cardiac atrium—coronary artery disease	4.56e-05	0.067	CbGeAlD
Olmesartan—AGTR1—blood—coronary artery disease	3.98e-05	0.0585	CbGeAlD
Olmesartan—SLCO1B1—blood—coronary artery disease	3.8e-05	0.0558	CbGeAlD
Olmesartan—Losartan—ACE—coronary artery disease	3.56e-05	0.0235	CrCbGaD
Olmesartan—Valsartan—ALB—coronary artery disease	2.99e-05	0.0197	CrCbGaD
Olmesartan—ABCC2—blood—coronary artery disease	2.88e-05	0.0423	CbGeAlD
Olmesartan—Losartan—CYP2C19—coronary artery disease	2.63e-05	0.0173	CrCbGaD
Olmesartan—Ill-defined disorder—Lisinopril—coronary artery disease	1.53e-05	0.00025	CcSEcCtD
Olmesartan—Discomfort—Ramipril—coronary artery disease	1.53e-05	0.00025	CcSEcCtD
Olmesartan—Headache—Clopidogrel—coronary artery disease	1.53e-05	0.00025	CcSEcCtD
Olmesartan—Rash—Lovastatin—coronary artery disease	1.53e-05	0.00025	CcSEcCtD
Olmesartan—Dermatitis—Lovastatin—coronary artery disease	1.53e-05	0.000249	CcSEcCtD
Olmesartan—Anaemia—Lisinopril—coronary artery disease	1.52e-05	0.000249	CcSEcCtD
Olmesartan—Dyspepsia—Losartan—coronary artery disease	1.52e-05	0.000249	CcSEcCtD
Olmesartan—Feeling abnormal—Perindopril—coronary artery disease	1.52e-05	0.000249	CcSEcCtD
Olmesartan—Headache—Lovastatin—coronary artery disease	1.52e-05	0.000248	CcSEcCtD
Olmesartan—Pruritus—Valsartan—coronary artery disease	1.51e-05	0.000247	CcSEcCtD
Olmesartan—Chest pain—Timolol—coronary artery disease	1.51e-05	0.000247	CcSEcCtD
Olmesartan—Myalgia—Timolol—coronary artery disease	1.51e-05	0.000247	CcSEcCtD
Olmesartan—Arthralgia—Timolol—coronary artery disease	1.51e-05	0.000247	CcSEcCtD
Olmesartan—Vomiting—Ezetimibe—coronary artery disease	1.51e-05	0.000247	CcSEcCtD
Olmesartan—Gastrointestinal pain—Perindopril—coronary artery disease	1.51e-05	0.000247	CcSEcCtD
Olmesartan—Anxiety—Timolol—coronary artery disease	1.51e-05	0.000247	CcSEcCtD
Olmesartan—Angioedema—Lisinopril—coronary artery disease	1.51e-05	0.000246	CcSEcCtD
Olmesartan—Decreased appetite—Losartan—coronary artery disease	1.5e-05	0.000246	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	1.5e-05	0.000246	CcSEcCtD
Olmesartan—Abdominal pain—Captopril—coronary artery disease	1.5e-05	0.000246	CcSEcCtD
Olmesartan—Body temperature increased—Captopril—coronary artery disease	1.5e-05	0.000246	CcSEcCtD
Olmesartan—Dizziness—Simvastatin—coronary artery disease	1.5e-05	0.000245	CcSEcCtD
Olmesartan—Rash—Ezetimibe—coronary artery disease	1.5e-05	0.000245	CcSEcCtD
Olmesartan—Dermatitis—Ezetimibe—coronary artery disease	1.5e-05	0.000245	CcSEcCtD
Olmesartan—Discomfort—Timolol—coronary artery disease	1.5e-05	0.000244	CcSEcCtD
Olmesartan—Asthenia—Niacin—coronary artery disease	1.49e-05	0.000244	CcSEcCtD
Olmesartan—Fatigue—Losartan—coronary artery disease	1.49e-05	0.000244	CcSEcCtD
Olmesartan—Headache—Ezetimibe—coronary artery disease	1.49e-05	0.000243	CcSEcCtD
Olmesartan—Malaise—Lisinopril—coronary artery disease	1.49e-05	0.000243	CcSEcCtD
Olmesartan—Oedema—Ramipril—coronary artery disease	1.48e-05	0.000243	CcSEcCtD
Olmesartan—Anaphylactic shock—Ramipril—coronary artery disease	1.48e-05	0.000243	CcSEcCtD
Olmesartan—Vertigo—Lisinopril—coronary artery disease	1.48e-05	0.000242	CcSEcCtD
Olmesartan—Pain—Losartan—coronary artery disease	1.48e-05	0.000242	CcSEcCtD
Olmesartan—Constipation—Losartan—coronary artery disease	1.48e-05	0.000242	CcSEcCtD
Olmesartan—Syncope—Lisinopril—coronary artery disease	1.48e-05	0.000242	CcSEcCtD
Olmesartan—Vomiting—Eplerenone—coronary artery disease	1.48e-05	0.000242	CcSEcCtD
Olmesartan—Feeling abnormal—Furosemide—coronary artery disease	1.48e-05	0.000242	CcSEcCtD
Olmesartan—Leukopenia—Lisinopril—coronary artery disease	1.48e-05	0.000241	CcSEcCtD
Olmesartan—Nausea—Fenofibrate—coronary artery disease	1.47e-05	0.000241	CcSEcCtD
Olmesartan—Pruritus—Niacin—coronary artery disease	1.47e-05	0.000241	CcSEcCtD
Olmesartan—Asthenia—Pravastatin—coronary artery disease	1.47e-05	0.00024	CcSEcCtD
Olmesartan—Gastrointestinal pain—Furosemide—coronary artery disease	1.47e-05	0.00024	CcSEcCtD
Olmesartan—Rash—Eplerenone—coronary artery disease	1.47e-05	0.00024	CcSEcCtD
Olmesartan—Urticaria—Perindopril—coronary artery disease	1.47e-05	0.00024	CcSEcCtD
Olmesartan—Dermatitis—Eplerenone—coronary artery disease	1.46e-05	0.000239	CcSEcCtD
Olmesartan—Diarrhoea—Valsartan—coronary artery disease	1.46e-05	0.000239	CcSEcCtD
Olmesartan—Shock—Ramipril—coronary artery disease	1.46e-05	0.000239	CcSEcCtD
Olmesartan—Losartan—ALB—coronary artery disease	1.46e-05	0.00962	CrCbGaD
Olmesartan—Body temperature increased—Perindopril—coronary artery disease	1.46e-05	0.000238	CcSEcCtD
Olmesartan—Abdominal pain—Perindopril—coronary artery disease	1.46e-05	0.000238	CcSEcCtD
Olmesartan—Palpitations—Lisinopril—coronary artery disease	1.46e-05	0.000238	CcSEcCtD
Olmesartan—Headache—Eplerenone—coronary artery disease	1.46e-05	0.000238	CcSEcCtD
Olmesartan—Nervous system disorder—Ramipril—coronary artery disease	1.46e-05	0.000238	CcSEcCtD
Olmesartan—Thrombocytopenia—Ramipril—coronary artery disease	1.45e-05	0.000237	CcSEcCtD
Olmesartan—Anaphylactic shock—Timolol—coronary artery disease	1.45e-05	0.000237	CcSEcCtD
Olmesartan—Oedema—Timolol—coronary artery disease	1.45e-05	0.000237	CcSEcCtD
Olmesartan—Pruritus—Pravastatin—coronary artery disease	1.45e-05	0.000237	CcSEcCtD
Olmesartan—Loss of consciousness—Lisinopril—coronary artery disease	1.45e-05	0.000237	CcSEcCtD
Olmesartan—Nausea—Clopidogrel—coronary artery disease	1.45e-05	0.000237	CcSEcCtD
Olmesartan—Tachycardia—Ramipril—coronary artery disease	1.45e-05	0.000237	CcSEcCtD
Olmesartan—Skin disorder—Ramipril—coronary artery disease	1.44e-05	0.000236	CcSEcCtD
Olmesartan—Infection—Timolol—coronary artery disease	1.44e-05	0.000236	CcSEcCtD
Olmesartan—Vomiting—Simvastatin—coronary artery disease	1.44e-05	0.000235	CcSEcCtD
Olmesartan—Cough—Lisinopril—coronary artery disease	1.44e-05	0.000235	CcSEcCtD
Olmesartan—Nausea—Lovastatin—coronary artery disease	1.44e-05	0.000235	CcSEcCtD
Olmesartan—Hyperhidrosis—Ramipril—coronary artery disease	1.43e-05	0.000234	CcSEcCtD
Olmesartan—Rash—Simvastatin—coronary artery disease	1.43e-05	0.000234	CcSEcCtD
Olmesartan—Dermatitis—Simvastatin—coronary artery disease	1.43e-05	0.000233	CcSEcCtD
Olmesartan—Asthenia—Trandolapril—coronary artery disease	1.43e-05	0.000233	CcSEcCtD
Olmesartan—Shock—Timolol—coronary artery disease	1.43e-05	0.000233	CcSEcCtD
Olmesartan—Feeling abnormal—Losartan—coronary artery disease	1.43e-05	0.000233	CcSEcCtD
Olmesartan—Urticaria—Furosemide—coronary artery disease	1.42e-05	0.000233	CcSEcCtD
Olmesartan—Diarrhoea—Niacin—coronary artery disease	1.42e-05	0.000233	CcSEcCtD
Olmesartan—Nervous system disorder—Timolol—coronary artery disease	1.42e-05	0.000233	CcSEcCtD
Olmesartan—Asthenia—Enalapril—coronary artery disease	1.42e-05	0.000232	CcSEcCtD
Olmesartan—Headache—Simvastatin—coronary artery disease	1.42e-05	0.000232	CcSEcCtD
Olmesartan—Abdominal pain—Furosemide—coronary artery disease	1.42e-05	0.000232	CcSEcCtD
Olmesartan—Body temperature increased—Furosemide—coronary artery disease	1.42e-05	0.000232	CcSEcCtD
Olmesartan—Gastrointestinal pain—Losartan—coronary artery disease	1.42e-05	0.000231	CcSEcCtD
Olmesartan—Dizziness—Valsartan—coronary artery disease	1.41e-05	0.000231	CcSEcCtD
Olmesartan—Anorexia—Ramipril—coronary artery disease	1.41e-05	0.000231	CcSEcCtD
Olmesartan—Nausea—Ezetimibe—coronary artery disease	1.41e-05	0.000231	CcSEcCtD
Olmesartan—Skin disorder—Timolol—coronary artery disease	1.41e-05	0.00023	CcSEcCtD
Olmesartan—Pruritus—Trandolapril—coronary artery disease	1.41e-05	0.00023	CcSEcCtD
Olmesartan—Chest pain—Lisinopril—coronary artery disease	1.4e-05	0.000229	CcSEcCtD
Olmesartan—Myalgia—Lisinopril—coronary artery disease	1.4e-05	0.000229	CcSEcCtD
Olmesartan—Arthralgia—Lisinopril—coronary artery disease	1.4e-05	0.000229	CcSEcCtD
Olmesartan—Hyperhidrosis—Timolol—coronary artery disease	1.4e-05	0.000229	CcSEcCtD
Olmesartan—Asthenia—Telmisartan—coronary artery disease	1.4e-05	0.000229	CcSEcCtD
Olmesartan—Pruritus—Enalapril—coronary artery disease	1.4e-05	0.000229	CcSEcCtD
Olmesartan—Diarrhoea—Pravastatin—coronary artery disease	1.4e-05	0.000229	CcSEcCtD
Olmesartan—Anxiety—Lisinopril—coronary artery disease	1.4e-05	0.000229	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.39e-05	0.000228	CcSEcCtD
Olmesartan—Discomfort—Lisinopril—coronary artery disease	1.39e-05	0.000227	CcSEcCtD
Olmesartan—Hypotension—Ramipril—coronary artery disease	1.39e-05	0.000227	CcSEcCtD
Olmesartan—Anorexia—Timolol—coronary artery disease	1.38e-05	0.000226	CcSEcCtD
Olmesartan—Pruritus—Telmisartan—coronary artery disease	1.38e-05	0.000226	CcSEcCtD
Olmesartan—Nausea—Eplerenone—coronary artery disease	1.38e-05	0.000226	CcSEcCtD
Olmesartan—Dizziness—Niacin—coronary artery disease	1.38e-05	0.000225	CcSEcCtD
Olmesartan—Urticaria—Losartan—coronary artery disease	1.37e-05	0.000225	CcSEcCtD
Olmesartan—Body temperature increased—Losartan—coronary artery disease	1.37e-05	0.000224	CcSEcCtD
Olmesartan—Abdominal pain—Losartan—coronary artery disease	1.37e-05	0.000224	CcSEcCtD
Olmesartan—Asthenia—Captopril—coronary artery disease	1.36e-05	0.000223	CcSEcCtD
Olmesartan—Diarrhoea—Trandolapril—coronary artery disease	1.36e-05	0.000222	CcSEcCtD
Olmesartan—Vomiting—Valsartan—coronary artery disease	1.36e-05	0.000222	CcSEcCtD
Olmesartan—Diarrhoea—Enalapril—coronary artery disease	1.36e-05	0.000222	CcSEcCtD
Olmesartan—Hypotension—Timolol—coronary artery disease	1.36e-05	0.000222	CcSEcCtD
Olmesartan—Dizziness—Pravastatin—coronary artery disease	1.35e-05	0.000221	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.35e-05	0.000221	CcSEcCtD
Olmesartan—Rash—Valsartan—coronary artery disease	1.35e-05	0.000221	CcSEcCtD
Olmesartan—Dermatitis—Valsartan—coronary artery disease	1.35e-05	0.00022	CcSEcCtD
Olmesartan—Nausea—Simvastatin—coronary artery disease	1.35e-05	0.00022	CcSEcCtD
Olmesartan—Anaphylactic shock—Lisinopril—coronary artery disease	1.35e-05	0.00022	CcSEcCtD
Olmesartan—Oedema—Lisinopril—coronary artery disease	1.35e-05	0.00022	CcSEcCtD
Olmesartan—Pruritus—Captopril—coronary artery disease	1.34e-05	0.00022	CcSEcCtD
Olmesartan—Insomnia—Ramipril—coronary artery disease	1.34e-05	0.000219	CcSEcCtD
Olmesartan—Headache—Valsartan—coronary artery disease	1.34e-05	0.000219	CcSEcCtD
Olmesartan—Diarrhoea—Telmisartan—coronary artery disease	1.34e-05	0.000219	CcSEcCtD
Olmesartan—Infection—Lisinopril—coronary artery disease	1.34e-05	0.000219	CcSEcCtD
Olmesartan—Shock—Lisinopril—coronary artery disease	1.32e-05	0.000216	CcSEcCtD
Olmesartan—Asthenia—Perindopril—coronary artery disease	1.32e-05	0.000216	CcSEcCtD
Olmesartan—Vomiting—Niacin—coronary artery disease	1.32e-05	0.000216	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Timolol—coronary artery disease	1.32e-05	0.000216	CcSEcCtD
Olmesartan—Thrombocytopenia—Lisinopril—coronary artery disease	1.32e-05	0.000215	CcSEcCtD
Olmesartan—Dizziness—Trandolapril—coronary artery disease	1.32e-05	0.000215	CcSEcCtD
Olmesartan—Tachycardia—Lisinopril—coronary artery disease	1.31e-05	0.000215	CcSEcCtD
Olmesartan—Insomnia—Timolol—coronary artery disease	1.31e-05	0.000214	CcSEcCtD
Olmesartan—Rash—Niacin—coronary artery disease	1.31e-05	0.000214	CcSEcCtD
Olmesartan—Dermatitis—Niacin—coronary artery disease	1.31e-05	0.000214	CcSEcCtD
Olmesartan—Dizziness—Enalapril—coronary artery disease	1.31e-05	0.000214	CcSEcCtD
Olmesartan—Skin disorder—Lisinopril—coronary artery disease	1.31e-05	0.000214	CcSEcCtD
Olmesartan—Dyspepsia—Ramipril—coronary artery disease	1.31e-05	0.000214	CcSEcCtD
Olmesartan—Pruritus—Perindopril—coronary artery disease	1.31e-05	0.000213	CcSEcCtD
Olmesartan—Headache—Niacin—coronary artery disease	1.3e-05	0.000213	CcSEcCtD
Olmesartan—Vomiting—Pravastatin—coronary artery disease	1.3e-05	0.000213	CcSEcCtD
Olmesartan—Hyperhidrosis—Lisinopril—coronary artery disease	1.3e-05	0.000213	CcSEcCtD
Olmesartan—Diarrhoea—Captopril—coronary artery disease	1.3e-05	0.000213	CcSEcCtD
Olmesartan—Dizziness—Telmisartan—coronary artery disease	1.29e-05	0.000211	CcSEcCtD
Olmesartan—Rash—Pravastatin—coronary artery disease	1.29e-05	0.000211	CcSEcCtD
Olmesartan—Dermatitis—Pravastatin—coronary artery disease	1.29e-05	0.000211	CcSEcCtD
Olmesartan—Decreased appetite—Ramipril—coronary artery disease	1.29e-05	0.000211	CcSEcCtD
Olmesartan—Asthenia—Furosemide—coronary artery disease	1.29e-05	0.00021	CcSEcCtD
Olmesartan—Headache—Pravastatin—coronary artery disease	1.28e-05	0.00021	CcSEcCtD
Olmesartan—Anorexia—Lisinopril—coronary artery disease	1.28e-05	0.00021	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Ramipril—coronary artery disease	1.28e-05	0.000209	CcSEcCtD
Olmesartan—Fatigue—Ramipril—coronary artery disease	1.28e-05	0.000209	CcSEcCtD
Olmesartan—Dyspepsia—Timolol—coronary artery disease	1.28e-05	0.000209	CcSEcCtD
Olmesartan—Nausea—Valsartan—coronary artery disease	1.27e-05	0.000208	CcSEcCtD
Olmesartan—Pruritus—Furosemide—coronary artery disease	1.27e-05	0.000207	CcSEcCtD
Olmesartan—Constipation—Ramipril—coronary artery disease	1.27e-05	0.000207	CcSEcCtD
Olmesartan—Vomiting—Trandolapril—coronary artery disease	1.26e-05	0.000207	CcSEcCtD
Olmesartan—Diarrhoea—Perindopril—coronary artery disease	1.26e-05	0.000206	CcSEcCtD
Olmesartan—Decreased appetite—Timolol—coronary artery disease	1.26e-05	0.000206	CcSEcCtD
Olmesartan—Vomiting—Enalapril—coronary artery disease	1.26e-05	0.000206	CcSEcCtD
Olmesartan—Hypotension—Lisinopril—coronary artery disease	1.26e-05	0.000206	CcSEcCtD
Olmesartan—Dizziness—Captopril—coronary artery disease	1.26e-05	0.000205	CcSEcCtD
Olmesartan—Rash—Trandolapril—coronary artery disease	1.25e-05	0.000205	CcSEcCtD
Olmesartan—Dermatitis—Trandolapril—coronary artery disease	1.25e-05	0.000205	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Timolol—coronary artery disease	1.25e-05	0.000205	CcSEcCtD
Olmesartan—Fatigue—Timolol—coronary artery disease	1.25e-05	0.000204	CcSEcCtD
Olmesartan—Rash—Enalapril—coronary artery disease	1.25e-05	0.000204	CcSEcCtD
Olmesartan—Dermatitis—Enalapril—coronary artery disease	1.25e-05	0.000204	CcSEcCtD
Olmesartan—Headache—Trandolapril—coronary artery disease	1.25e-05	0.000204	CcSEcCtD
Olmesartan—Vomiting—Telmisartan—coronary artery disease	1.24e-05	0.000203	CcSEcCtD
Olmesartan—Asthenia—Losartan—coronary artery disease	1.24e-05	0.000203	CcSEcCtD
Olmesartan—Headache—Enalapril—coronary artery disease	1.24e-05	0.000203	CcSEcCtD
Olmesartan—Pain—Timolol—coronary artery disease	1.24e-05	0.000203	CcSEcCtD
Olmesartan—Nausea—Niacin—coronary artery disease	1.24e-05	0.000202	CcSEcCtD
Olmesartan—Rash—Telmisartan—coronary artery disease	1.23e-05	0.000201	CcSEcCtD
Olmesartan—Dermatitis—Telmisartan—coronary artery disease	1.23e-05	0.000201	CcSEcCtD
Olmesartan—Diarrhoea—Furosemide—coronary artery disease	1.23e-05	0.000201	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.23e-05	0.0002	CcSEcCtD
Olmesartan—Pruritus—Losartan—coronary artery disease	1.22e-05	0.0002	CcSEcCtD
Olmesartan—Headache—Telmisartan—coronary artery disease	1.22e-05	0.0002	CcSEcCtD
Olmesartan—Feeling abnormal—Ramipril—coronary artery disease	1.22e-05	0.0002	CcSEcCtD
Olmesartan—Dizziness—Perindopril—coronary artery disease	1.22e-05	0.000199	CcSEcCtD
Olmesartan—Insomnia—Lisinopril—coronary artery disease	1.22e-05	0.000199	CcSEcCtD
Olmesartan—Nausea—Pravastatin—coronary artery disease	1.22e-05	0.000199	CcSEcCtD
Olmesartan—Gastrointestinal pain—Ramipril—coronary artery disease	1.21e-05	0.000198	CcSEcCtD
Olmesartan—Vomiting—Captopril—coronary artery disease	1.21e-05	0.000198	CcSEcCtD
Olmesartan—Rash—Captopril—coronary artery disease	1.2e-05	0.000196	CcSEcCtD
Olmesartan—Dermatitis—Captopril—coronary artery disease	1.2e-05	0.000196	CcSEcCtD
Olmesartan—Feeling abnormal—Timolol—coronary artery disease	1.2e-05	0.000195	CcSEcCtD
Olmesartan—Headache—Captopril—coronary artery disease	1.19e-05	0.000195	CcSEcCtD
Olmesartan—Gastrointestinal pain—Timolol—coronary artery disease	1.19e-05	0.000194	CcSEcCtD
Olmesartan—Dizziness—Furosemide—coronary artery disease	1.19e-05	0.000194	CcSEcCtD
Olmesartan—Dyspepsia—Lisinopril—coronary artery disease	1.18e-05	0.000194	CcSEcCtD
Olmesartan—Diarrhoea—Losartan—coronary artery disease	1.18e-05	0.000194	CcSEcCtD
Olmesartan—Nausea—Trandolapril—coronary artery disease	1.18e-05	0.000193	CcSEcCtD
Olmesartan—Urticaria—Ramipril—coronary artery disease	1.18e-05	0.000193	CcSEcCtD
Olmesartan—Nausea—Enalapril—coronary artery disease	1.18e-05	0.000192	CcSEcCtD
Olmesartan—Vomiting—Perindopril—coronary artery disease	1.17e-05	0.000192	CcSEcCtD
Olmesartan—Abdominal pain—Ramipril—coronary artery disease	1.17e-05	0.000192	CcSEcCtD
Olmesartan—Body temperature increased—Ramipril—coronary artery disease	1.17e-05	0.000192	CcSEcCtD
Olmesartan—Decreased appetite—Lisinopril—coronary artery disease	1.17e-05	0.000191	CcSEcCtD
Olmesartan—Rash—Perindopril—coronary artery disease	1.16e-05	0.00019	CcSEcCtD
Olmesartan—Dermatitis—Perindopril—coronary artery disease	1.16e-05	0.00019	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.16e-05	0.00019	CcSEcCtD
Olmesartan—Nausea—Telmisartan—coronary artery disease	1.16e-05	0.00019	CcSEcCtD
Olmesartan—Fatigue—Lisinopril—coronary artery disease	1.16e-05	0.00019	CcSEcCtD
Olmesartan—Headache—Perindopril—coronary artery disease	1.16e-05	0.000189	CcSEcCtD
Olmesartan—Urticaria—Timolol—coronary artery disease	1.15e-05	0.000188	CcSEcCtD
Olmesartan—Pain—Lisinopril—coronary artery disease	1.15e-05	0.000188	CcSEcCtD
Olmesartan—Constipation—Lisinopril—coronary artery disease	1.15e-05	0.000188	CcSEcCtD
Olmesartan—Abdominal pain—Timolol—coronary artery disease	1.15e-05	0.000187	CcSEcCtD
Olmesartan—Body temperature increased—Timolol—coronary artery disease	1.15e-05	0.000187	CcSEcCtD
Olmesartan—Dizziness—Losartan—coronary artery disease	1.14e-05	0.000187	CcSEcCtD
Olmesartan—Vomiting—Furosemide—coronary artery disease	1.14e-05	0.000186	CcSEcCtD
Olmesartan—Rash—Furosemide—coronary artery disease	1.13e-05	0.000185	CcSEcCtD
Olmesartan—Dermatitis—Furosemide—coronary artery disease	1.13e-05	0.000185	CcSEcCtD
Olmesartan—Nausea—Captopril—coronary artery disease	1.13e-05	0.000185	CcSEcCtD
Olmesartan—Headache—Furosemide—coronary artery disease	1.12e-05	0.000184	CcSEcCtD
Olmesartan—Feeling abnormal—Lisinopril—coronary artery disease	1.11e-05	0.000181	CcSEcCtD
Olmesartan—Gastrointestinal pain—Lisinopril—coronary artery disease	1.1e-05	0.00018	CcSEcCtD
Olmesartan—Vomiting—Losartan—coronary artery disease	1.1e-05	0.00018	CcSEcCtD
Olmesartan—Nausea—Perindopril—coronary artery disease	1.1e-05	0.000179	CcSEcCtD
Olmesartan—Rash—Losartan—coronary artery disease	1.09e-05	0.000178	CcSEcCtD
Olmesartan—Dermatitis—Losartan—coronary artery disease	1.09e-05	0.000178	CcSEcCtD
Olmesartan—Headache—Losartan—coronary artery disease	1.08e-05	0.000177	CcSEcCtD
Olmesartan—Urticaria—Lisinopril—coronary artery disease	1.07e-05	0.000175	CcSEcCtD
Olmesartan—Nausea—Furosemide—coronary artery disease	1.07e-05	0.000174	CcSEcCtD
Olmesartan—Asthenia—Ramipril—coronary artery disease	1.06e-05	0.000174	CcSEcCtD
Olmesartan—Abdominal pain—Lisinopril—coronary artery disease	1.06e-05	0.000174	CcSEcCtD
Olmesartan—Body temperature increased—Lisinopril—coronary artery disease	1.06e-05	0.000174	CcSEcCtD
Olmesartan—Pruritus—Ramipril—coronary artery disease	1.05e-05	0.000172	CcSEcCtD
Olmesartan—Asthenia—Timolol—coronary artery disease	1.04e-05	0.00017	CcSEcCtD
Olmesartan—Nausea—Losartan—coronary artery disease	1.03e-05	0.000168	CcSEcCtD
Olmesartan—Pruritus—Timolol—coronary artery disease	1.03e-05	0.000168	CcSEcCtD
Olmesartan—Diarrhoea—Ramipril—coronary artery disease	1.02e-05	0.000166	CcSEcCtD
Olmesartan—Diarrhoea—Timolol—coronary artery disease	9.93e-06	0.000162	CcSEcCtD
Olmesartan—Dizziness—Ramipril—coronary artery disease	9.81e-06	0.00016	CcSEcCtD
Olmesartan—Asthenia—Lisinopril—coronary artery disease	9.66e-06	0.000158	CcSEcCtD
Olmesartan—Dizziness—Timolol—coronary artery disease	9.59e-06	0.000157	CcSEcCtD
Olmesartan—Pruritus—Lisinopril—coronary artery disease	9.52e-06	0.000156	CcSEcCtD
Olmesartan—Vomiting—Ramipril—coronary artery disease	9.43e-06	0.000154	CcSEcCtD
Olmesartan—Rash—Ramipril—coronary artery disease	9.36e-06	0.000153	CcSEcCtD
Olmesartan—Dermatitis—Ramipril—coronary artery disease	9.35e-06	0.000153	CcSEcCtD
Olmesartan—Headache—Ramipril—coronary artery disease	9.3e-06	0.000152	CcSEcCtD
Olmesartan—Vomiting—Timolol—coronary artery disease	9.22e-06	0.000151	CcSEcCtD
Olmesartan—Diarrhoea—Lisinopril—coronary artery disease	9.21e-06	0.000151	CcSEcCtD
Olmesartan—Rash—Timolol—coronary artery disease	9.15e-06	0.00015	CcSEcCtD
Olmesartan—Dermatitis—Timolol—coronary artery disease	9.14e-06	0.000149	CcSEcCtD
Olmesartan—Headache—Timolol—coronary artery disease	9.09e-06	0.000149	CcSEcCtD
Olmesartan—Dizziness—Lisinopril—coronary artery disease	8.9e-06	0.000145	CcSEcCtD
Olmesartan—Nausea—Ramipril—coronary artery disease	8.81e-06	0.000144	CcSEcCtD
Olmesartan—Nausea—Timolol—coronary artery disease	8.62e-06	0.000141	CcSEcCtD
Olmesartan—Vomiting—Lisinopril—coronary artery disease	8.56e-06	0.00014	CcSEcCtD
Olmesartan—Rash—Lisinopril—coronary artery disease	8.49e-06	0.000139	CcSEcCtD
Olmesartan—Dermatitis—Lisinopril—coronary artery disease	8.48e-06	0.000139	CcSEcCtD
Olmesartan—Headache—Lisinopril—coronary artery disease	8.43e-06	0.000138	CcSEcCtD
Olmesartan—Nausea—Lisinopril—coronary artery disease	7.99e-06	0.000131	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—ALDH2—coronary artery disease	6.34e-06	0.000299	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDN1—coronary artery disease	6.3e-06	0.000298	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	6.29e-06	0.000297	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL5—coronary artery disease	6.25e-06	0.000295	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	6.25e-06	0.000295	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCD—coronary artery disease	6.2e-06	0.000293	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.18e-06	0.000292	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HBA1—coronary artery disease	6.18e-06	0.000292	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LIPC—coronary artery disease	6.18e-06	0.000292	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2C19—coronary artery disease	6.18e-06	0.000292	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3C2A—coronary artery disease	6.18e-06	0.000292	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CSF2—coronary artery disease	6.16e-06	0.000291	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PDHA1—coronary artery disease	6.14e-06	0.00029	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCLM—coronary artery disease	6.14e-06	0.00029	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOC3—coronary artery disease	6.14e-06	0.00029	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LDLR—coronary artery disease	6.1e-06	0.000288	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.09e-06	0.000288	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR3—coronary artery disease	6.07e-06	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR2A—coronary artery disease	6.07e-06	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—C3—coronary artery disease	6.06e-06	0.000286	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOB—coronary artery disease	6.03e-06	0.000285	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTT1—coronary artery disease	6.03e-06	0.000285	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC9A1—coronary artery disease	6.03e-06	0.000285	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CRK—coronary artery disease	5.99e-06	0.000283	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GCLC—coronary artery disease	5.96e-06	0.000281	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CETP—coronary artery disease	5.96e-06	0.000281	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	5.96e-06	0.000281	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP11B2—coronary artery disease	5.95e-06	0.000281	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TXNRD1—coronary artery disease	5.95e-06	0.000281	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VWF—coronary artery disease	5.92e-06	0.00028	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SH2B3—coronary artery disease	5.92e-06	0.00028	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ATP2A2—coronary artery disease	5.92e-06	0.00028	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	5.91e-06	0.000279	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SDC1—coronary artery disease	5.89e-06	0.000278	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOC3—coronary artery disease	5.88e-06	0.000278	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC22A3—coronary artery disease	5.86e-06	0.000277	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LDLR—coronary artery disease	5.85e-06	0.000276	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HADH—coronary artery disease	5.78e-06	0.000273	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ARNTL—coronary artery disease	5.78e-06	0.000273	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGT—coronary artery disease	5.76e-06	0.000272	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PPP2CA—coronary artery disease	5.74e-06	0.000271	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL2—coronary artery disease	5.71e-06	0.00027	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL3—coronary artery disease	5.71e-06	0.00027	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	5.69e-06	0.000269	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOB—coronary artery disease	5.66e-06	0.000267	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2R—coronary artery disease	5.65e-06	0.000267	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SDC1—coronary artery disease	5.65e-06	0.000267	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCD—coronary artery disease	5.63e-06	0.000266	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PSMA6—coronary artery disease	5.57e-06	0.000263	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PSMB5—coronary artery disease	5.57e-06	0.000263	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.56e-06	0.000262	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	5.55e-06	0.000262	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGB—coronary artery disease	5.53e-06	0.000261	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2A—coronary artery disease	5.51e-06	0.00026	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C3—coronary artery disease	5.51e-06	0.00026	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA2—coronary artery disease	5.48e-06	0.000259	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLA2G2A—coronary artery disease	5.48e-06	0.000259	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX2—coronary artery disease	5.48e-06	0.000259	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDNRB—coronary artery disease	5.47e-06	0.000258	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CTGF—coronary artery disease	5.44e-06	0.000257	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HK1—coronary artery disease	5.41e-06	0.000255	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX4—coronary artery disease	5.41e-06	0.000255	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SULT1A1—coronary artery disease	5.41e-06	0.000255	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG5—coronary artery disease	5.41e-06	0.000255	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	5.4e-06	0.000255	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMGCR—coronary artery disease	5.39e-06	0.000255	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GOT2—coronary artery disease	5.39e-06	0.000255	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—THBS1—coronary artery disease	5.39e-06	0.000254	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HADHA—coronary artery disease	5.34e-06	0.000252	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PSMA6—coronary artery disease	5.33e-06	0.000252	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PSMB5—coronary artery disease	5.33e-06	0.000252	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2—coronary artery disease	5.32e-06	0.000251	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—coronary artery disease	5.28e-06	0.00025	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA1—coronary artery disease	5.28e-06	0.00025	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGT—coronary artery disease	5.23e-06	0.000247	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPA—coronary artery disease	5.22e-06	0.000247	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDNRA—coronary artery disease	5.16e-06	0.000244	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB1—coronary artery disease	5.14e-06	0.000243	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CYBA—coronary artery disease	5.14e-06	0.000243	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DUSP6—coronary artery disease	5.12e-06	0.000242	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLCB3—coronary artery disease	5.06e-06	0.000239	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLAT—coronary artery disease	5.03e-06	0.000238	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA5—coronary artery disease	5.01e-06	0.000237	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLCB1—coronary artery disease	4.96e-06	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—P4HB—coronary artery disease	4.91e-06	0.000232	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.86e-06	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.86e-06	0.00023	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BDKRB2—coronary artery disease	4.86e-06	0.000229	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL12—coronary artery disease	4.86e-06	0.000229	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—coronary artery disease	4.85e-06	0.000229	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2—coronary artery disease	4.83e-06	0.000228	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLA2G1B—coronary artery disease	4.82e-06	0.000228	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6ST—coronary artery disease	4.81e-06	0.000227	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCA1—coronary artery disease	4.8e-06	0.000227	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOA1—coronary artery disease	4.77e-06	0.000225	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.77e-06	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JUNB—coronary artery disease	4.77e-06	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLCB1—coronary artery disease	4.75e-06	0.000224	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.71e-06	0.000223	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GOT1—coronary artery disease	4.65e-06	0.00022	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GGT1—coronary artery disease	4.65e-06	0.00022	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR7—coronary artery disease	4.65e-06	0.00022	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—VCAN—coronary artery disease	4.54e-06	0.000215	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDOA—coronary artery disease	4.51e-06	0.000213	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—coronary artery disease	4.48e-06	0.000212	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ITGAV—coronary artery disease	4.43e-06	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KNG1—coronary artery disease	4.42e-06	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—coronary artery disease	4.4e-06	0.000208	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CREB1—coronary artery disease	4.4e-06	0.000208	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—DCN—coronary artery disease	4.38e-06	0.000207	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—coronary artery disease	4.31e-06	0.000203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6R—coronary artery disease	4.29e-06	0.000203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL10—coronary artery disease	4.29e-06	0.000203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLG—coronary artery disease	4.28e-06	0.000202	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDH2—coronary artery disease	4.26e-06	0.000201	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTP1—coronary artery disease	4.18e-06	0.000197	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB2—coronary artery disease	4.17e-06	0.000197	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.15e-06	0.000196	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HBA1—coronary artery disease	4.15e-06	0.000196	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LIPC—coronary artery disease	4.15e-06	0.000196	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2C19—coronary artery disease	4.15e-06	0.000196	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3C2A—coronary artery disease	4.15e-06	0.000196	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARGC1A—coronary artery disease	4.14e-06	0.000196	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOC3—coronary artery disease	4.12e-06	0.000195	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—coronary artery disease	4.12e-06	0.000195	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCE—coronary artery disease	4.11e-06	0.000194	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—JAK2—coronary artery disease	4.11e-06	0.000194	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SOCS1—coronary artery disease	4.1e-06	0.000194	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LDLR—coronary artery disease	4.1e-06	0.000194	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.09e-06	0.000193	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—S100B—coronary artery disease	4.09e-06	0.000193	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—coronary artery disease	4.07e-06	0.000192	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SOCS3—coronary artery disease	4.05e-06	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC9A1—coronary artery disease	4.05e-06	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTT1—coronary artery disease	4.05e-06	0.000191	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFBR2—coronary artery disease	4e-06	0.000189	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KITLG—coronary artery disease	4e-06	0.000189	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CETP—coronary artery disease	4e-06	0.000189	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCLC—coronary artery disease	4e-06	0.000189	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SDC1—coronary artery disease	3.96e-06	0.000187	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOB—coronary artery disease	3.95e-06	0.000186	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP3—coronary artery disease	3.91e-06	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT5A—coronary artery disease	3.91e-06	0.000185	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—coronary artery disease	3.84e-06	0.000181	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOB—coronary artery disease	3.78e-06	0.000179	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—coronary artery disease	3.78e-06	0.000179	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPL—coronary artery disease	3.77e-06	0.000178	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—coronary artery disease	3.75e-06	0.000177	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PSMB5—coronary artery disease	3.74e-06	0.000177	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PSMA6—coronary artery disease	3.74e-06	0.000177	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.73e-06	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—JAK2—coronary artery disease	3.73e-06	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDN1—coronary artery disease	3.72e-06	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL5—coronary artery disease	3.69e-06	0.000174	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GPX1—coronary artery disease	3.68e-06	0.000174	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CTGF—coronary artery disease	3.65e-06	0.000173	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF1—coronary artery disease	3.64e-06	0.000172	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CSF2—coronary artery disease	3.64e-06	0.000172	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GOT2—coronary artery disease	3.62e-06	0.000171	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMGCR—coronary artery disease	3.62e-06	0.000171	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LPL—coronary artery disease	3.61e-06	0.000171	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CD36—coronary artery disease	3.58e-06	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MEF2C—coronary artery disease	3.58e-06	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RPS6KB1—coronary artery disease	3.58e-06	0.000169	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.55e-06	0.000168	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPP2CA—coronary artery disease	3.54e-06	0.000167	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ITGB3—coronary artery disease	3.49e-06	0.000165	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—coronary artery disease	3.41e-06	0.000161	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—coronary artery disease	3.39e-06	0.00016	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PPP2CA—coronary artery disease	3.39e-06	0.00016	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLCB1—coronary artery disease	3.33e-06	0.000157	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCD—coronary artery disease	3.33e-06	0.000157	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.27e-06	0.000154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2A—coronary artery disease	3.26e-06	0.000154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C3—coronary artery disease	3.25e-06	0.000154	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCA1—coronary artery disease	3.23e-06	0.000152	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AGT—coronary artery disease	3.22e-06	0.000152	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOE—coronary artery disease	3.16e-06	0.000149	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GGT1—coronary artery disease	3.13e-06	0.000148	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GOT1—coronary artery disease	3.13e-06	0.000148	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA1—coronary artery disease	3.12e-06	0.000148	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIF1A—coronary artery disease	3.1e-06	0.000146	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGT—coronary artery disease	3.09e-06	0.000146	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—coronary artery disease	3.03e-06	0.000143	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOE—coronary artery disease	3.03e-06	0.000143	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOA1—coronary artery disease	2.99e-06	0.000141	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.99e-06	0.000141	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KDR—coronary artery disease	2.97e-06	0.00014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK14—coronary artery disease	2.95e-06	0.000139	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ESR1—coronary artery disease	2.89e-06	0.000137	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FN1—coronary artery disease	2.86e-06	0.000135	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2—coronary artery disease	2.86e-06	0.000135	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6ST—coronary artery disease	2.84e-06	0.000134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFKBIA—coronary artery disease	2.82e-06	0.000133	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTP1—coronary artery disease	2.81e-06	0.000133	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARGC1A—coronary artery disease	2.78e-06	0.000131	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—coronary artery disease	2.77e-06	0.000131	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—coronary artery disease	2.75e-06	0.00013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KIT—coronary artery disease	2.73e-06	0.000129	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—coronary artery disease	2.73e-06	0.000129	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—coronary artery disease	2.71e-06	0.000128	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOB—coronary artery disease	2.65e-06	0.000125	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GSK3B—coronary artery disease	2.62e-06	0.000124	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—coronary artery disease	2.6e-06	0.000123	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CREB1—coronary artery disease	2.6e-06	0.000123	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—coronary artery disease	2.58e-06	0.000122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—coronary artery disease	2.54e-06	0.00012	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6R—coronary artery disease	2.54e-06	0.00012	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPL—coronary artery disease	2.53e-06	0.00012	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—coronary artery disease	2.5e-06	0.000118	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAPK1—coronary artery disease	2.49e-06	0.000118	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—coronary artery disease	2.47e-06	0.000117	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX1—coronary artery disease	2.47e-06	0.000117	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CD36—coronary artery disease	2.41e-06	0.000114	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.38e-06	0.000112	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPP2CA—coronary artery disease	2.38e-06	0.000112	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—coronary artery disease	2.38e-06	0.000112	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—coronary artery disease	2.37e-06	0.000112	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF2—coronary artery disease	2.3e-06	0.000109	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—coronary artery disease	2.28e-06	0.000108	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—coronary artery disease	2.27e-06	0.000107	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JAK2—coronary artery disease	2.2e-06	0.000104	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AGT—coronary artery disease	2.17e-06	0.000102	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—coronary artery disease	2.16e-06	0.000102	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CA—coronary artery disease	2.16e-06	0.000102	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOE—coronary artery disease	2.12e-06	0.0001	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA1—coronary artery disease	2.1e-06	9.91e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—coronary artery disease	2.01e-06	9.5e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.01e-06	9.49e-05	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—coronary artery disease	1.94e-06	9.18e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—coronary artery disease	1.93e-06	9.1e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—coronary artery disease	1.91e-06	9.04e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCND1—coronary artery disease	1.87e-06	8.85e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—coronary artery disease	1.85e-06	8.73e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—coronary artery disease	1.82e-06	8.61e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—coronary artery disease	1.82e-06	8.6e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—coronary artery disease	1.76e-06	8.34e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—coronary artery disease	1.66e-06	7.85e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—coronary artery disease	1.63e-06	7.72e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—coronary artery disease	1.59e-06	7.51e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—coronary artery disease	1.5e-06	7.08e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK1—coronary artery disease	1.47e-06	6.95e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—coronary artery disease	1.45e-06	6.87e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CA—coronary artery disease	1.33e-06	6.29e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CA—coronary artery disease	1.28e-06	6.03e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—coronary artery disease	1.13e-06	5.34e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—coronary artery disease	1.09e-06	5.14e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—coronary artery disease	1.04e-06	4.92e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	8.95e-07	4.23e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—coronary artery disease	7.31e-07	3.45e-05	CbGpPWpGaD
